NOVOPEN Echo Plus Insulin Pen

Product Information

Novo Nordisk has signed collaboration agreements with Glooko, Roche and DexCom to support the future integration of its NovoPen 6 and NovoPen Echo Plus insulin pens with digital health solutions. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorisation of Abbott Laboratories, except to identify the product or services of the company. mmol/L) per day, with a reduction in time spent in hyperglycaemia (measured as HbA 1c >10 mmol/L) and level 2 hypoglycaemia (measured as HbA 1c <3.

NovoPen® 6 | Hypodermic insulin injection pens | Medical NovoPen® 6 | Hypodermic insulin injection pens | Medical

Remote access to this data may also help to support a longer- term transition from in-person to virtual care, during and after the COVID-19 pandemic, which could also help alleviate pressure on health system capacity. Diabetes Professional Care 2023 The UK's only free-to-attend and CPD certified conference and exhibition for HCPs seeking key suppliers, solutions and products for effective diabetes care. Smart pens can be used without any smart connectivity, but the added benefits of the pens can be seen once you download the pen data onto the integrated app. The attachment will transmit the insulin dose, time of dose, and the type of insulin being injected to a phone app (an important safety precaution to avoid mix-ups). The data can also tell you how much insulin is still working in your body which can help you make decisions for unplanned activity or unexpected sugar readings.A leading global healthcare company has launched two smart connected insulin pens in the UK to improve the lives of people living with diabetes.

Novo Nordisk two smart insulin pens available on prescription

NovoPen ® 6 / NovoPen Echo ® Plus have been available to purchase in pharmacies from September 12 this year. James Ridgeway, 34, is a diabetes specialist nurse (DSN) with type 1 diabetes who has seen both the personal and professional side of using smart insulin pens. In the meantime, we believe it is important to make NovoPen ® 6 and NovoPen Echo ® Plus available now to those people who wish to use this technology to help manage their diabetes. She added: “In my clinic, the opportunity to view daily insulin data will allow me to better support the individual with diabetes to achieve their goals. Commenting on the interoperability between the smart pens and FreeStyle LibreLink, James says: “I have found registering NovoPen devices onto the LibreLink app very simple for myself and people in my clinic.

For example, you can upload data from your blood glucose meter, CGM or flash glucose monitor and view your insulin dosing data alongside this, which can help you to identify patterns.

Novo Nordisk Smart Pens, Devices and Apps | Novo Nordisk

In the Swedish pilot, the pens were downloaded in the healthcare provider’s office using a kiosk (see picture below) – the goal was to improve the conversation between the person with diabetes and the healthcare provider, combining insulin data with glucose data. I would use the Echo Plus for my rapid-acting insulin injections, and the NovoPen 6 for my long-acting insulin.Reusable Novo Nordisk smart insulin pens will launch first, followed by a Bluetooth attachment for disposable pens later in 2019. Echo Plus and NovoPen 6 will be compatible with both long-acting basal insulin (Levemir, Tresiba) and short-acting mealtime insulin (NovoLog, Fiasp).

What does the dose memory display show? - medicines

It will allow for more tailored and informed advice on optimisation of glucose levels, with the ultimate goal of improving future outcomes.Smart insulin pens, also known as connected pens, can be used by and are beneficial to people with all forms of diabetes that inject insulin, whether you finger-prick and use blood glucose meters, or you use CGMs or flash glucose monitors.